Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2072119rdf:typepubmed:Citationlld:pubmed
pubmed-article:2072119lifeskim:mentionsumls-concept:C0079259lld:lifeskim
pubmed-article:2072119lifeskim:mentionsumls-concept:C0013264lld:lifeskim
pubmed-article:2072119lifeskim:mentionsumls-concept:C1742737lld:lifeskim
pubmed-article:2072119pubmed:issue2lld:pubmed
pubmed-article:2072119pubmed:dateCreated1991-8-19lld:pubmed
pubmed-article:2072119pubmed:abstractTextDystrophin, the protein product of the Duchenne muscular dystrophy (DMD) gene, was studied in needle biopsy samples taken from the quadriceps muscle of 15 asymptomatic carriers of DMD (13 adults and 2 young girls) and one symptomatic adult carrier. Antibodies to N- and C-terminal regions of dystrophin were used for both Western blot analysis and immunocytochemistry and a monoclonal antibody to beta-spectrin used to assess membrane integrity. All asymptomatic adult carriers showed some abnormality in dystrophin immunostaining but very few negative fibres were present. A clear mosaic of dystrophin positive and negative fibres was seen only in the adult symptomatic carrier and the two young girls. On a Western blot, all carriers studied had dystrophin of normal molecular weight, but most had reduced abundance. In adult carriers, the amount of dystrophin relative to normal controls varied, but it was unrelated to age, serum creatine kinase (CK) levels or to the degree of pathology. Carriers with normal CK showed abnormalities in dystrophin expression. The dystrophin immunoblotting profile of the 2 young girls was very similar to that of their mothers, but the mosaic pattern of immunostaining was not apparent in the older carriers. In conclusion, dystrophin immunostaining and Western blot analysis of biopsy samples from asymptomatic carriers is often abnormal and they may be useful additional aids for establishing carrier status, particularly in younger girls.lld:pubmed
pubmed-article:2072119pubmed:languageenglld:pubmed
pubmed-article:2072119pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2072119pubmed:citationSubsetIMlld:pubmed
pubmed-article:2072119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2072119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2072119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2072119pubmed:statusMEDLINElld:pubmed
pubmed-article:2072119pubmed:monthAprlld:pubmed
pubmed-article:2072119pubmed:issn0022-510Xlld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:StrongP NPNlld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:DubowitzVVlld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:HeckmattJ ZJZlld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:RodilloEElld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:ClerkAAlld:pubmed
pubmed-article:2072119pubmed:authorpubmed-author:SewryC ACAlld:pubmed
pubmed-article:2072119pubmed:issnTypePrintlld:pubmed
pubmed-article:2072119pubmed:volume102lld:pubmed
pubmed-article:2072119pubmed:ownerNLMlld:pubmed
pubmed-article:2072119pubmed:authorsCompleteYlld:pubmed
pubmed-article:2072119pubmed:pagination197-205lld:pubmed
pubmed-article:2072119pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:meshHeadingpubmed-meshheading:2072119-...lld:pubmed
pubmed-article:2072119pubmed:year1991lld:pubmed
pubmed-article:2072119pubmed:articleTitleCharacterisation of dystrophin in carriers of Duchenne muscular dystrophy.lld:pubmed
pubmed-article:2072119pubmed:affiliationJerry Lewis Muscle Research Centre, Department of Paediatrics and Neonatal Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.lld:pubmed
pubmed-article:2072119pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2072119pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2072119lld:pubmed